Form 4 for FLGT Fulgent Genetics, Inc.

Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001253820-26-000001 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-03-02	2026-02-26+	FLGT	Kim Paul	CFO, Treas	F - Tax	$16.36	-10.6K	368.5K	-3%	-$174.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-01	F	D	1,133	$15.33	376,894	D	—	—	(F2) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, , which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.
2	Common	Common Stock	2026-02-26	F	D	1,168	$24.76	378,027	D	—	—	(F1) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
3	Common	Common Stock	2026-03-01	F	D	8,347	$15.33	368,547	D	—	—	(F3) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.